Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities
AIRNA develops RNA editing technologies to create medicines for various diseases.
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
Santa Ana Bio is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Basking Biosciences is to commercialize technology developed at Duke and Ohio State Universities.
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
RTW Investments has invested in 107 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RTW Investments's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 13 different industry categories.
Among tracked funding rounds, Mineralys Therapeutics received $287.5M in a Post Ipo Equity round. RTW Investments's total known invested capital is $13.3B.
RTW Investments's average investment size is $131.3M across its portfolio of 107 companies.
Recent RTW Investments portfolio additions include Oruka Therapeutics, Mineralys Therapeutics, Arvinas, Alcyone Therapeutics, AIRNA. These companies were founded in 2020 or later.